Compare BridgeBio Pharma Inc (BBIO) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Western Digital Corp — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Western Digital Corp trades at $449.51 (market cap $150.95B). The key difference: Western Digital Corp is far larger — about 9.2× BridgeBio Pharma Inc's market cap, and Western Digital Corp pays a 0.14% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | WDC | |
|---|---|---|
Market Cap | $16.36B | $150.95B |
Sector | Health | Technology |
52-Week High | $90.17 | $746.23 |
52-Week Low | $47.29 | $74.66 |
Enterprise Value | $18.14B | $150.42B |
Dividend Yield | — | 0.14% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
